Dr. Reddy's surges on launching generic version of Sapropterin Dihydrochloride Tablets

05 Oct 2020 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 5145.75, up by 33.10 points or 0.65% from its previous closing of Rs. 5112.65 on the BSE.

The scrip opened at Rs. 5155.00 and has touched a high and low of Rs. 5165.00 and Rs. 5102.30 respectively. So far 19690 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 2497.60 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 5315.45 and Rs. 5067.20 respectively. The current market cap of the company is Rs. 85519.77 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.97% and 15.25% respectively.

Dr. Reddy’s Laboratories has launched a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. The company’s Sapropterin Dihydrochloride Tablets, 100 mg are available in bottle count sizes of 120.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1267.15 -7.90 (-0.62%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×